Immune response monitoring in breast cancer patients treated with neoadjuvant chemotherapy combined with dendritic cell vaccines

被引：1
|
作者：
Hato, Laura
Inoges, Susana
Perez, Belen
Mejias, Luis
Sanchez-Bayona, Rodrigo
Santisteban, Marta
Lopez, Ascension
机构：
来源：
CANCER RESEARCH | 2022年 / 82卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS21-P2-14-11
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-14-11
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [31] Usefulness of PET/MRI in predicting complete response in breast cancer patients treated with neoadjuvant chemotherapy
    Sekine, Chikako
    CANCER RESEARCH, 2020, 80 (04)
  • [32] Tumor Response Ratio Predicts Overall Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
    Marian Miller
    Rebecca A. Ottesen
    Joyce C. Niland
    Laura Kruper
    Steven L. Chen
    Courtney Vito
    Annals of Surgical Oncology, 2014, 21 : 3317 - 3323
  • [33] Concordance between radiologic and pathologic complete response in patients with breast cancer treated with neoadjuvant chemotherapy
    Garrigos, Laia
    Dolors Sabadell, Maria
    Rodriguez-Arana, Ana
    Maria Corominas, Josep
    Martinez-Garcia, Maria
    Gonzalez, Iria
    Martos, Tamara
    Albanell, Joan
    Tusquets, Ignacio
    Servitja, Sonia
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Phase II study of autologous dendritic cell vaccination in patients with HER2 negative breast cancer combined with neoadjuvant chemotherapy
    Castillo, A.
    Salgado, E.
    Inoges, S.
    Arevalo, E.
    Castanon, E.
    Lopez, Diaz de Cerio A.
    Sola, J. J.
    Pina, L.
    Nunez, J.
    Rodriguez-Spiteri, N.
    Espinos, J.
    Aramendia, J. M.
    Fernandez, Hidalgo O. A.
    Santisteban, M.
    CANCER RESEARCH, 2012, 72
  • [35] Added value of systemic inflammation markers for monitoring response to neoadjuvant chemotherapy in breast cancer patients
    Zi-Rui Ke
    Wei Chen
    Man-Xiu Li
    Shun Wu
    Li-Ting Jin
    Tie-Jun Wang
    World Journal of Clinical Cases, 2022, (11) : 3389 - 3400
  • [36] FDG PET/CT for early monitoring of response to neoadjuvant chemotherapy in breast cancer patients.
    Andrade, W.
    Soares, F.
    Lima, E.
    Maciel, MdS
    Toledo, C.
    Lyeyasu, H.
    Cruz, M.
    Fanelli, M.
    CANCER RESEARCH, 2012, 72
  • [37] Added value of systemic inflammation markers for monitoring response to neoadjuvant chemotherapy in breast cancer patients
    Ke, Zi-Rui
    Chen, Wei
    Li, Man-Xiu
    Wu, Shun
    Jin, Li-Ting
    Wang, Tie-Jun
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (11) : 3389 - 3400
  • [38] RADIONUCLIDE EVALUATION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN BREAST CANCER PATIENTS
    Solodyannikova, O.
    RADIOTHERAPY AND ONCOLOGY, 2010, 94 : S30 - S30
  • [39] Response to neoadjuvant chemotherapy in patients with triple negative breast cancer
    Abe, E.
    Hayashi, N.
    Yoshida, A.
    Hamaoka, T.
    Yagata, H.
    Tsugawa, K.
    Tsunoda-Shimizu, H.
    Suzuki, K.
    Nakamura, S.
    CANCER RESEARCH, 2009, 69 (02) : 367S - 367S
  • [40] Radionuclide evaluation of response to neoadjuvant chemotherapy in breast cancer patients
    Solodyannikova, O.
    Voit, N.
    Dzhuzha, D.
    Sukach, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S305 - S305
12345